Dataset Information


Ubiquilin 2 is not associated with tau pathology.

ABSTRACT: Accumulation of aberrant proteins in inclusion bodies is a hallmark of many neurodegenerative diseases. Impairment of proteolytic systems is a common event in these protein misfolding diseases. Recently, mutations in the UBQLN 2 gene encoding ubiquilin 2 have been identified in X-linked amyotrophic lateral sclerosis (ALS). Furthermore, ubiquilin 2 is associated with inclusions in familial and sporadic ALS/dementia, synucleinopathies and polyglutamine diseases. Ubiquilin 2 exerts a regulatory role in proteostasis and thus it has been suggested that ubiquilin 2 pathology may be a common event in neurodegenerative diseases. Tauopathies, a heterogenous group of neurodegenerative diseases accompanied with dementia, are characterized by inclusions of the microtubule-binding protein tau. In the present study, we investigate whether ubiquilin 2 is connected with tau pathology in Alzheimer's disease (AD), supranuclear palsy (PSP) and Pick's disease (PiD) and familial cases with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). We show that ubiquilin 2 positive inclusions are absent in these tauopathies. Furthermore, we find decreased ubiquilin 2 protein levels in AD patients, but our results do not indicate a correlation with tau pathology. Our data show no evidence for involvement of ubiquilin 2 and indicate that other mechanisms underly the proteostatic disturbances in tauopathies.


PROVIDER: S-EPMC3784422 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC3914001 | BioStudies
2012-01-01 | S-EPMC3521561 | BioStudies
2018-01-01 | S-EPMC5880389 | BioStudies
2015-01-01 | S-EPMC4495639 | BioStudies
2016-01-01 | S-EPMC4662611 | BioStudies
| S-EPMC2726961 | BioStudies
2016-01-01 | S-EPMC5116305 | BioStudies
1000-01-01 | S-EPMC2658102 | BioStudies
2019-01-01 | S-EPMC6404306 | BioStudies
1000-01-01 | S-EPMC3677441 | BioStudies